XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]        
Revenue $ 257 $ 204 $ 941 $ 1,050
Cost of revenue (153) (71) (476) (488)
Gross profit 104 133 465 562
Selling, general and administrative expenses (1,130) (2,228) (3,841) (5,272)
Research and development expenses (852) (903) (2,658) (2,918)
Operating loss (1,878) (2,998) (6,034) (7,628)
Impairment Loss on PPE 0 (2,623) 0 (2,623)
Other income, net 49 32 110 136
Loss before income taxes (1,829) (5,589) (5,924) (10,115)
Income tax expense 0 0 0 0
Net loss attributable to common stockholders (1,829) (5,589) (5,924) (10,115)
Foreign currency translation adjustments (18) 18 (36) (36)
Comprehensive loss $ (1,847) $ (5,571) $ (5,960) $ (10,151)
Net loss per share attributable to common stockholders:        
Basic and diluted (in Dollars per share) $ (0.02) $ (0.09) $ (0.08) $ (0.18)
Basic and diluted (in Dollars per share) $ (0.02) $ (0.09) $ (0.08) $ (0.18)
Weighted-average number of shares used in computing net loss per share amounts: (in Shares) 77,633,004 63,725,084 75,494,270 57,039,035
Weighted-average number of shares used in computing net loss per share amounts: (in Shares) 77,633,004 63,725,084 75,494,270 57,039,035